MDCorp (MDCX) P/S (2016 - 2026)
MDCorp (MDCX) P/S from Feb 3, 2016 to Jun 3, 2026. The TTM MDCorp (MDCX) P/S is 130.02. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of MDCorp (MDCX)
| Year | P/S | Change |
|---|---|---|
| 2026 | 130.02 | -83.12% |
| 2025 | 770.39 | -19.51% |
| 2024 | 957.15 | +5384.32% |
| 2018 | 17.45 | +616.42% |
| 2017 | 2.44 | +346.67% |
| 2016 | 0.55 | N/A |
Comparison MDCorp (MDCX) P/S with competitors
MDCorp (MDCX) P/S is 130.02.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -99.56% |
| NVO | Novo Nordisk | 0.60 | -99.54% |
| GRFS | Grifols SA | 0.74 | -99.43% |
| AMRN | Amarin Corp | 1.38 | -98.94% |
| SCLX | Scilex Holding Company | 1.50 | -98.85% |
| SNY | Sanofi | 2.24 | -98.28% |
| PFE | Pfizer Inc | 2.36 | -98.19% |
| BMY | Bristol-Myers Squibb Company | 2.42 | -98.14% |
| BIIB | Biogen Inc | 2.91 | -97.76% |
| GSK | GSK Plc | 3.16 | -97.57% |
| MRK | Merck & Co Inc | 4.51 | -96.53% |
| AZN | Astrazeneca plc | 4.75 | -96.34% |
| AMGN | AMGEN Inc | 4.87 | -96.25% |
| NVS | Novartis AG | 5.10 | -96.08% |
| GILD | Gilead Sciences Inc | 5.58 | -95.71% |
| JNJ | Johnson & Johnson | 5.78 | -95.55% |
| ABBV | Abbvie Inc | 6.06 | -95.34% |
| LLY | Lilly(Eli) & Company | 13.37 | -89.72% |